Differentiation and Retinoids
Part of the Pediatric Oncology book series (PEDIATRICO)
KeywordsRetinoic Acid Neural Crest Neural Crest Cell Retinoic Acid Receptor Human Neuroblastoma Cell Line
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Corazzari M, Lovat PE, Oliverio S, Pearson AD, Piacentini M, Redfern CP (2003) Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastoma. Mol Pharmacol 64:1370–1378CrossRefPubMedGoogle Scholar
- Le Dourain N, Kalcheim C (1999) The neural crest, 2nd edn. Cambridge University Press, New YorkGoogle Scholar
- Tweddle DA, Malcolm AJ, Bown N, Pearson AD, Lunec J (2001) Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res 61:8–13Google Scholar
- Villablanca JG, Ames MM, Reid JM, Bagniewski PG, Krailo M, Reynolds CP (2002) Phase I trial of oral N-(4-hydroxyphenyl) retinamide (4-HPR) in children with resistant/recurrent solid tumors: a Childrens Cancer Group Study (CCG 09709). Proc Am Soc Clin Oncol 21:1558Google Scholar
© Springer-Verlag Berlin Heidelberg 2005